colecalciferol aristo 20,000 iu soft capsules
aristo pharma gmbh - colecalciferol - capsule, soft - 20,000 international unit(s) - vitamin d and analogues; colecalciferol
alendronate/colecalciferol teva 70 mg/2800 iu tablets
teva pharma b.v. - vitamin d3; alendronic acid - tablet - 70 mg/2800 international unit(s) - bisphosphonates, combinations; alendronic acid and colecalciferol
alendronate/colecalciferol teva 70 mg/5600 iu tablets
teva pharma b.v. - vitamin d3; alendronic acid - tablet - 70 mg/5600 international unit(s) - bisphosphonates, combinations; alendronic acid and colecalciferol
colecalciferol 20,000unit capsules
colonis pharma ltd - colecalciferol - capsule - 20000unit
colecalciferol 30000 iu film-coated tablets
consilient health limited - colecalciferol - film-coated tablet - 30000 international unit(s) - vitamin d and analogues; colecalciferol
alendronate/colecalciferol rowex 70 mg/5600 iu tablets
rowex ltd - alendronic acid; vitamin d3 - tablet - 70 mg/5600 international unit(s) - bisphosphonates, combinations; alendronic acid and colecalciferol
colecalciferol 800unit tablets
consilient health ltd - colecalciferol - tablet - 800unit
alendronate - 1 a pharma plus colecalciferol tablets 70mg, 5600iu
1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - alendronic acid, colecalciferol - tablet - alendronic acid 70 mg colecalciferol 140 µg - drugs for treatment of bone diseases
vantavo (previously alendronate sodium and colecalciferol, msd)
n.v. organon - alendronic acid, colecalciferol - osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of postmenopausal osteoporosis in patients at risk of vitamin-d insufficiency.vantavo reduces the risk of vertebral and hip fractures.treatment of postmenopausal osteoporosis in patients who are not receiving vitamin-d supplementation and are at risk of vitamin-d insufficiency.vantavo reduces the risk of vertebral and hip fractures.
alendronate plus d3 sandoz 70 mg/140 microgram alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 iu) tablet b
dr reddys laboratories australia pty ltd - colecalciferol, quantity: 0.14 mg; alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg) - tablet, uncoated - excipient ingredients: gelatin; croscarmellose sodium; butylated hydroxytoluene; colloidal anhydrous silica; sucrose; magnesium stearate; microcrystalline cellulose; povidone; medium chain triglycerides - tradenames are indicated for the treatment of: ? osteoporosis* in select patients where vitamin d supplementation is recommended,* prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture